Qiagen NV/ NL0015001WM6 /
2024-05-10 10:10:00 PM | Chg. +0.03 | Volume | Bid1:48:20 AM | Ask1:48:20 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
43.61USD | +0.07% | 655,246 Turnover: 23.48 mill. |
42.98Bid Size: 100 | 44.16Ask Size: 100 | 9.95 bill.USD | - | 29.08 |
GlobeNewswire
05-07
QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics
GlobeNewswire
05-02
QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inher...
GlobeNewswire
04-29
QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance
GlobeNewswire
04-25
deepull unveils 1 hour, direct-from-blood multiplex PCR test for 95% of sepsis-causing pathogens at ...
GlobeNewswire
04-24
QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and comba...
GlobeNewswire
04-18
deepull appoints Kimberle Chapin, MD, as Chief Medical Officer and Wade Stevenson as Chief Marketing...
GlobeNewswire
04-03
QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Ann...
GlobeNewswire
03-25
QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration a...
GlobeNewswire
03-18
QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosi...
GlobeNewswire
02-27
QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery
GlobeNewswire
02-27
QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Plati...
GlobeNewswire
02-15
QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Plati...
GlobeNewswire
02-06
QIAGEN exceeds outlook for Q4 2023, led by 8% CER sales growth in non-COVID products and improved op...
GlobeNewswire
01-25
QIAGEN announces partnership with Penn State University to advance microbiome sciences
GlobeNewswire
01-18
QIAGEN announces details for completion of synthetic share repurchase of up to approximately $300 mi...
GlobeNewswire
01-08
QIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 Molecular Sy...
GlobeNewswire
01-04
QIAGEN to accelerate investments into QIAGEN Digital Insights bioinformatics business